cell therapy

New data show that NK cell engagers may provide a robust alternative to T cell therapies.

Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.

Bristol Myers Squibb unveiled promising CAR T cell therapy data for severe autoimmune diseases from their Phase 1 clinical trial, offering hope for remission.

Exhilarated but cautious, researchers are eager to see if CAR T cell therapy offers a one-time treatment for lupus.

A modular CAR T cell could make cancer therapy safer and more effective.

Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.

Researchers harvest stem cells from patients who have recently had a heart attack and use them to trigger regeneration of their cardiac muscle.

A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.

T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.

Researchers mix gene editing with the principles of martial arts to boost T cell therapies.